Authors:
Cullen, JM
Ll, DH
Brown, C
Eisenberg, EJ
Cundy, KC
Wolfe, J
Toole, J
Gibbs, C
Citation: Jm. Cullen et al., Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks, ANTIM AG CH, 45(10), 2001, pp. 2740-2745
Authors:
Lalani, N
Noyce, D
Adinolfi, J
Axelson, P
Barlow, J
Bentzen, BL
Bolt, S
Carroll, J
Christo, A
Davis, R
Denney, C
Denny, C
De Robertis, M
Douglas, B
Edmonston, R
Edwards, D
Fegan, J
Garren, S
Gellings, J
Henson, C
Jones, M
Kastenhofer, E
Killingsworth, R
Kirschbaum, J
Laplante, J
Lipman, A
Marshall, R
Moe, P
Moeur, R
Moffat, J
Nodes, S
Oliver, T
Quinlan, K
Ridgway, M
St Jacques, K
Thibualt, L
Thompson, H
Toole, J
Walsh, T
Watkins, K
Webb, P
Weinberger, S
Wetmore, J
Wilkinson, B
Zegeer, C
Zimny, B
Citation: N. Lalani et al., ITE Pedestrian and Bicycle Task Force, ITE J, 70(9), 2000, pp. 22-24
Citation: Rjc. Gilson et al., A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection, J VIRAL HEP, 6(5), 1999, pp. 387-395